Related Experiment Video
Updated: Jan 15, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Impact of material characteristics on nanoparticle penetration and retention in thrombi: implications for
Xiangxun Chen1,2, Haotian Cha2, Shehzahdi S Moonshi1,2
1School of Environment and Science, Griffith University, Nathan Campus, Brisbane, Queensland, QLD 4111, Australia. h.ta@griffith.edu.au.
Insights
Nanoparticle properties like size, charge, and material significantly impact thrombus penetration for treating blood clots. Silver nanoparticles with negative charges show better distribution within thrombi compared to gold ones.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cardiovascular Research
Background:
- Ischemic cardiovascular disease is a leading global cause of death, often due to thrombi.
- Current thrombolytic therapies often neglect nanoparticle distribution within thrombi.
- Developing targeted nanomaterials for thrombus penetration is crucial for effective treatment.
Purpose of the Study:
- To systematically investigate how nanoparticle physicochemical properties influence thrombus penetration and distribution.
- To guide the design of advanced thrombolytic nanomaterials.
- To optimize nanoparticle delivery for treating blood clots.
Main Methods:
- Utilized gold and silver nanoparticles of varying sizes (10-200 nm), charges (positive/negative), and shapes (spherical/rod).
- Employed two-photon microscopy, loop-based diffusion, and microchannel thrombus models (static and dynamic).
- Evaluated nanoparticle penetration, distribution, and retention within thrombi.
Main Results:
- Nanoparticle physicochemical properties significantly affect thrombus penetration and accumulation.
- Larger particle size decreased penetration but increased retention.
- Negative surface charge and silver material enhanced particle penetration over positive charges and gold.
- Rod-shaped nanoparticles exhibited reduced penetration and increased retention.
Conclusions:
- Nanoparticle size, charge, material, and shape are critical factors for thrombus targeting.
- Findings provide essential insights for designing effective diagnostic and therapeutic nanoparticles for cardiovascular diseases.
- Optimized nanoparticle design can improve thrombolytic therapy efficacy.
Abstract:
Ischemic cardiovascular disease is the leading cause of death worldwide and is primarily attributed to blood vessel occlusion caused by thrombi. While current treatments and research focus on overall thrombolytic activity, they often overlook the distribution of therapeutic agents or drug-loaded nanomaterials within the thrombus. This study is the first to systematically investigate how the material, size, shape, and charge of nanoparticles affect their ability to penetrate and distribute within a thrombus. The ultimate goal is to guide the development of more efficient thrombolytic nanomaterials. Recently, various metal (e.g. gold and silver) and metal oxide nanomaterials have been developed for thrombolysis and molecular imaging of thrombi. Based on this, we employed gold and silver nanoparticles in our study. Nanoparticles ranging from 10 to 200 nm in size, with both positive and negative surface charges, and in spherical and rod-shaped forms, were evaluated using two-photon microscopy, loop-based diffusion, and both static and dynamic microchannel thrombus models. It was found that the physicochemical characteristics of nanoparticles strongly influence their ability to penetrate and accumulate within the thrombus. In particular, the larger the particle size, the lower the penetration and the higher the retention. Negative surface charge and silver materials favour penetration of the particles compared to positively charged or gold particles, respectively. Particle shape is also an influence factor, where a rod shape reduces penetration and increases retention. These findings provide valuable insights for designing future diagnostic and therapeutic nanoparticles.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Clot Retraction and Fibrinolysis
Venous Thrombosis I: Introduction

